Teenage cannabinoid exposure changed how adult mice responded to cocaine withdrawal | Research

The takeaway

Mice exposed to a synthetic cannabinoid during adolescence showed altered cocaine withdrawal effects as adults: reduced anxiety but increased depressive symptoms compared to controls.

Read this if you're interested in how adolescent cannabis exposure might change the experience of other drug withdrawals later in life.

Adolescent cannabinoid exposure prevented cocaine withdrawal anxiety but increased depression-like behavior

What the researchers found

Mice pre-treated with the synthetic cannabinoid WIN 55212-2 during adolescence and then given chronic cocaine in adulthood showed a modified withdrawal profile compared to controls.

Adolescent cannabinoid exposure prevented the anxiety increase normally seen during cocaine withdrawal. However, it produced greater depressive-like symptoms during cocaine cessation. The psychotic-like effects of WIN (measured by pre-pulse inhibition deficits) persisted into adulthood regardless of cocaine exposure, and memory impairment during cocaine withdrawal was not altered by prior cannabinoid treatment.

The results suggest that adolescent cannabinoid exposure does not simply worsen all cocaine withdrawal symptoms but selectively modifies the emotional dimensions of withdrawal.

Why it matters

Cannabis use in adolescence has been epidemiologically linked to later cocaine use, but the biological mechanisms are poorly understood. This study suggests that adolescent cannabinoid exposure creates lasting changes in how the brain responds to cocaine withdrawal, potentially altering the experience of quitting cocaine in ways that could affect relapse.

The numbers in context

Adolescent WIN pre-treatment prevented cocaine withdrawal-induced anxiety (elevated plus maze) but increased depressive-like behavior (tail suspension test). Pre-pulse inhibition deficits from WIN persisted independently of cocaine exposure. Object recognition impairment during cocaine withdrawal was unaffected by prior WIN exposure.

How the study worked

Juvenile mice received the CB1 agonist WIN 55212-2 during adolescence, then underwent chronic cocaine treatment in adulthood followed by withdrawal. Researchers tested four behavioral domains during withdrawal: pre-pulse inhibition (psychosis-like), object recognition (memory), elevated plus maze (anxiety), and tail suspension (depression-like).

What this study cannot tell us

Used a synthetic cannabinoid (WIN 55212-2), which is more potent and selective than THC. The doses and administration route differ from human cannabis use. Mouse behavioral tests are approximations of human psychiatric symptoms. The study did not examine females.

How to read the evidence

Animal study using a synthetic cannabinoid in mice. Provides mechanistic insight into cross-drug interactions but uses compounds and routes different from human use.

When this study was published

Published in 2017. Described as the first study to show long-lasting behavioral consequences of juvenile cannabinoid exposure on cocaine withdrawal.

The bigger picture

The finding that adolescent cannabinoid exposure selectively modifies cocaine withdrawal adds nuance to the "gateway drug" discussion. Rather than simply increasing vulnerability, early cannabinoid exposure appears to reshape the emotional landscape of subsequent drug withdrawal in complex ways, potentially making some aspects easier and others harder.

Questions still open

Would THC produce the same modification of cocaine withdrawal effects? Does the reduced anxiety but increased depression during withdrawal affect relapse likelihood? How do these behavioral changes map onto the neurotransmitter systems involved?

Common questions

Does teenage cannabis use make cocaine withdrawal worse?

In this mouse study, the picture was mixed. Adolescent cannabinoid exposure actually reduced anxiety during cocaine withdrawal but increased depressive symptoms. The overall effect on withdrawal severity depends on which dimension you examine.

Is this related to the gateway drug theory?

It addresses one possible mechanism: that early cannabinoid exposure biologically alters how the brain later responds to other drugs and their withdrawal. However, it does not support a simple "cannabis leads to cocaine" narrative, as the effects were selective and mixed.

Read the original research

Adolescent Exposure to the Synthetic Cannabinoid WIN 55212-2 Modifies Cocaine Withdrawal Symptoms in Adult Mice.

International journal of molecular sciences, 18(6)

View on PubMed ↗Publisher’s paper ↗

Citation

Aguilar, María A; Ledesma, Juan Carlos; Rodríguez-Arias, Marta; Penalva, Carles; Manzanedo, Carmen; Miñarro, José; Arenas, M Carmen. (2017). Adolescent Exposure to the Synthetic Cannabinoid WIN 55212-2 Modifies Cocaine Withdrawal Symptoms in Adult Mice.. International journal of molecular sciences, 18(6). https://doi.org/10.3390/ijms18061326